Detection of Circulating Tumour DNA in the Blood (Plasma/Serum) of Cancer Patients

Small amounts of free DNA circulate in both healthy and diseased human plasma/serum, and increased concentrations of DNA are present in the plasma of cancer patients. Characteristics of tumour DNA have been found in genetic material extracted from the plasma of cancer patients. These features include decreased strand stability and the presence of specific oncogene, tumour suppressor gene and microsatellite alterations. Point mutations of the ras genes have been detected in the plasma DNA of patients suffering from haematopoetic malignancies, colorectal and pancreatic cancer, sometimes prior to clinical diagnosis. Rearranged immunoglobulin heavy chain DNA has been found in the plasma of patients with non-Hodgkins lymphoma and acute B cell leukaemia. Microsatellite instability, expressed either as a new allele or a loss of one allele (LOH) occurs in the plasma and serum DNA of patients suffering from head and neck, lung and renal cell cancer. The results obtained in many different cancers have opened a new research area indicating that plasma DNA might eventually be a suitable target for the development of non-invasive diagnostic, prognostic and follow-up tests for cancer.

[1]  V. Vasioukhin,et al.  K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. , 1997, Gastroenterology.

[2]  I. Sargent,et al.  Presence of fetal DNA in maternal plasma and serum , 1997, The Lancet.

[3]  M. Stroun,et al.  Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system. , 1975, Cancer research.

[4]  N. M. Hjelm,et al.  Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients , 1998, The Lancet.

[5]  Y. Shiratori,et al.  Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. , 1996, Gastroenterology.

[6]  R. Rosell,et al.  Detection of chromosome 3p alterations in serum DNA of non-small-cell lung cancer patients. , 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  P Mandel,et al.  Les acides nucleiques du plasma sanguin chez l' homme , 1948 .

[8]  C. Steinman,et al.  Plasma DNA in systemic lupus erythematosus. Characterization of cloned base sequences. , 1989, Arthritis and rheumatism.

[9]  R. Winchester,et al.  The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. , 1973, The Journal of clinical investigation.

[10]  Valeri Vasioukhin,et al.  Point mutations of the N‐ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia , 1994, British journal of haematology.

[11]  F. Laval,et al.  Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. , 1995, Cancer letters.

[12]  J. Schell,et al.  Large plasmid in Agrobacterium tumefaciens essential for crown gall-inducing ability , 1974, Nature.

[13]  P. Schur,et al.  Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. , 1966, The Journal of clinical investigation.

[14]  C. Steinman,et al.  Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. , 1990, The Journal of clinical investigation.

[15]  A. Verhest,et al.  Philadelphia chromosome-positive thrombocythemia with leukemic transformation. , 1983, The New England journal of medicine.

[16]  D. Swinkels,et al.  Detection of tumour DNA in serum of colorectal cancer patients. , 1997, Scandinavian journal of clinical and laboratory investigation.

[17]  M. Stroun,et al.  Neoplastic characteristics of the DNA found in the plasma of cancer patients. , 1989, Oncology.

[18]  C. Valeri,et al.  Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Stroun,et al.  Nucleic acids spontaneously released by living frog auricles. , 1972, The Biochemical journal.

[20]  B. Vogelstein,et al.  Prevalence of ras gene mutations in human colorectal cancers , 1987, Nature.

[21]  G. Jacobson,et al.  Mutations of p53 gene can be detected in the plasma of patients with large bowel carcinoma. , 1998, Journal of clinical pathology.

[22]  B. Shapiro,et al.  Radioimmunoassay for nanogram quantities of DNA. , 1975, Journal of immunological methods.

[23]  P. Lambert,et al.  RELEASE OF DNA IN CIRCULATING BLOOD AND INDUCTION OF ANTI-DNA ANTIBODIES AFTER INJECTION OF BACTERIAL LIPOPOLYSACCHARIDES , 1974, The Journal of experimental medicine.

[24]  A. Maebo,et al.  [Plasma DNA level as a tumor marker in primary lung cancer]. , 1990, Nihon Kyobu Shikkan Gakkai zasshi.

[25]  K. Iczkowski,et al.  Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. , 1998, Pancreas.

[26]  M. Stroun,et al.  Bacterial Ribonucleic Acid in the Frog Brain after a Bacterial Peritoneal Infection , 1972, Science.

[27]  J. Rogers,et al.  Capping of DNA on phytohemagglutinin-stimulated human lymphoblasts. , 1981, Journal of immunology.

[28]  J. Rogers.  Identification of an intracellular precursor to DNA excreted by human lymphocytes. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[29]  P. Schur,et al.  Deoxyribonucleic Acid ( DNA ) and Antibodies to DNA in the Serum of Patients with Systemic Lupus Erythematosus * , 2022 .

[30]  J. Herman,et al.  Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. , 1999, Cancer research.

[31]  Y S Erozan,et al.  Microsatellite alterations as clonal markers for the detection of human cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T K Lau,et al.  Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. , 1998, American journal of human genetics.

[33]  V A Memoli,et al.  Soluble normal and mutated DNA sequences from single-copy genes in human blood. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[34]  F. A. Benko,et al.  Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. , 1997, British Journal of Cancer.

[35]  M. Stroun,et al.  Transcription of Spontaneously Released Bacterial Deoxyribonucleic Acid in Frog Auricles , 1973, Journal of bacteriology.

[36]  A. Kurt,et al.  Microsatellite alterations in plasma DNA of small cell lung cancer patients , 1996, Nature Medicine.

[37]  C. Steinman.  Free DNA in serum and plasma from normal adults. , 1975, The Journal of clinical investigation.

[38]  C. Marshall,et al.  Mutational activation of the N-ras oncogene assessed in primary clonogenic culture of acute myeloid leukemia (AML): implications for the role of N-ras mutation in AML pathogenesis. , 1992, Blood.

[39]  R. Hruban,et al.  Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. , 1994, Cancer research.

[40]  H. Heimpel,et al.  Rearranged Ig heavy chain DNA is detectable in cell-free blood samples of patients with B-cell neoplasia. , 1997, Blood.

[41]  David Sidransky,et al.  Microsatellite alterations in serum DNA of head and neck cancer patients , 1996, Nature Medicine.

[42]  E. Dimagno,et al.  Genetic markers: the key to early diagnosis and improved survival in pancreatic cancer? , 1996, Gastroenterology.

[43]  B. Shapiro,et al.  Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease , 1983, Cancer.

[44]  M. Stroun,et al.  Isolation and characterization of DNA from the plasma of cancer patients. , 1987, European journal of cancer & clinical oncology.

[45]  K. Miller,et al.  Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. , 1998, Cancer research.

[46]  H. Greppin,et al.  Agrobacterium tumefaciens Ribonucleic Acid Synthesis in Tomato Cells and Crown Gall Induction , 1971, Journal of bacteriology.

[47]  B. Shapiro,et al.  Free DNA in the serum of cancer patients and the effect of therapy. , 1977, Cancer research.

[48]  H. Mano,et al.  A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome , 1987, Nature.

[49]  J. Jen,et al.  Molecular detection of genetic alterations in the serum of colorectal cancer patients. , 1998, Cancer research.

[50]  K. Pantel,et al.  Diagnosis and therapeutic relevance of micrometastases. , 1998, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[51]  A. Yanagisawa,et al.  Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. , 1993, Cancer research.

[52]  D. Shibata,et al.  Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes , 1988, Cell.

[53]  Jose M. Silva,et al.  TP53 gene mutations in plasma DNA of cancer patients , 1999, Genes, chromosomes & cancer.

[54]  M. Stroun,et al.  Natural Release of Nucleic Acids from Bacteria into Plant Cells , 1970, Nature.